InsidersTradesSigma
Track the 바이오인프라 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 바이오인프라 has published 12 public disclosures. The latest transaction was filed on 8 June 2026 (Other). Among the most active insiders: 김장현. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
12 of 12 declarations
BioInfra is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance human health.